Hosted on MSN

FDA grants 510(k) clearance to 4DMedical’s CT:VQ for respiratory diagnostics

The US Food and Drug Administration (FDA) has granted 510(k) clearance to 4DMedical’s non-contrast, computed tomography (CT)-based ventilation-perfusion imaging technology, CT:VQ, for respiratory ...
Nasdaq

4DMedical Launches CT:VQ, Eyeing Billion-Dollar Market

4DMedical Limited has unveiled its innovative CT:VQ technology at RSNA 2024, offering a revolutionary alternative to traditional Nuclear VQ scans. This new imaging solution promises faster, safer, and ...
Yahoo Finance

4DMedical receives CE Mark for CT:VQ™, enabling commercial launch across the European Union

In a separate announcement made today, the Company also secured A$83 million in private placement funding to support growth initiatives, including European expansion. MELBOURNE, Australia, March 31, ...
Seeking Alpha

4DMedical Limited (FDMDF) Discusses Expansion of Distribution Agreement for CT:VQ Non-Contrast Lung Imaging Solution Transcript

Hey everybody. Really, thank you so much for joining this call. I'm incredibly appreciative of your interest. I hope you can bear with me. My voice is pretty hoarse. I've literally had hundreds and ...
Seeking Alpha

4DMedical Limited (FDMDF) Investor Webinar Transcript

Hi, everyone. Thank you so much for joining us today and for your interest in 4DMedical and today's investor presentation. Of course, the key focus of today's presentation is going to be CT:VQ post ...